https://www.selleckchem.com/pr....oducts/CP-690550.htm
To assess whether dynamic ventilation and perfusion (Q) biomarkers derived by phase-resolved functional lung (PREFUL) MRI can measure treatment response to 14-day therapy with indacaterol-glycopyrronium (IND-GLY) and correlate to clinical outcomes including lung function, symptoms, and cardiac function in patients with chronic obstructive pulmonary disease (COPD), as determined by spirometry, body plethysmography, cardiac MRI, and dyspnea score measurements. The cardiac left ventricular function in COPD (CLAIM) study enrolled patients
Aimer
Commentaire
Partagez
